Sign in

CIK 0001590750 · Large accelerated filer

Viridian Therapeutics, Inc.\DE

Sign in to watch
Ticker
VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471187261
Phone
617.272.4600
Business address
221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
Former names
MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
  1. CT ORDER Other Confidential Order
  2. 10-Q/A Report 10-Q/A
  3. CT ORDER Other Confidential Order
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations · Regulation FD disclosure
  6. CT ORDER Other Confidential Order
  7. 8-K Event Material agreement
  8. CT ORDER Other Confidential Order
  9. 8-K Event Material agreement · New debt or obligation
  10. 10-Q Report Quarterly Report
  11. 4 Insider Changes in Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 8-K Event Executive or director change · Regulation FD disclosure
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. CT ORDER Other Confidential Order
  18. S-8 Other Securities Offered to Employees in Benefit Plans
  19. 424B4 Offering Prospectus
  20. EFFECT Other Notice of Effectiveness

Page 39 of 41 · 819 filings